Results 251 to 260 of about 279,339 (314)

Impact of Tumor Location on the Efficacy of Lateral and Mesenteric Lymph Node Dissection in Patients With Rectal Cancer Treated by Upfront Surgery

Annals of Gastroenterological Surgery, EarlyView.
This study examined the impact of tumor location on lymph node metastasis (LNM) patterns and the efficacy of lymph node dissection in rectal cancer. Analyzing 882 patients who underwent total mesorectal excision with lateral lymph node dissection, we found that mesenteric LNM rates were higher in tumors located more orally, whereas lateral LNM rates ...
Tomofumi Uotani, Hiroshi Nagata, Yasuyuki Takamizawa, Konosuke Moritani, Shunsuke Tsukamoto, Tsutomu Fujii, Yukihide Kanemitsu   +6 more
wiley   +1 more source

Genomic profiles and prognostic biomarkers of resectable lung adenocarcinoma with a micropapillary component. [PDF]

Front Oncol
Zhu J, Sun X, Huang J, Lin W, Zhan Y, Yan J, Xu Y, Wu L, Lian Y, Zhang Z, Lin J.   +10 more
europepmc   +1 more source

Cell Membrane‐Coated Lipid Nanoparticles for Drug Delivery

Aggregate, EarlyView.
This review highlights recent progress in cell membrane‐coated lipid nanoparticles (CMC‐LNPs), focusing on their design, preparation methods, functional integration, and biomedical applications. It discusses various types of LNPs and coating strategies, characterization techniques, therapeutic functions, and applications.
Moataz B. Zewail, Guangze Yang, Yilong Fan, Yue Hui, Chun‐Xia Zhao, Yun Liu   +5 more
wiley   +1 more source

A Clinical-Radiomics Nomogram for the Preoperative Prediction of Aggressive Micropapillary and a Solid Pattern in Lung Adenocarcinoma. [PDF]

Curr Oncol
Xie X, Chen L, Li K, Shi L, Zhang L, Zheng L.   +5 more
europepmc   +1 more source

Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy

Aggregate, EarlyView.
Nanomaterial (NM)‐induced toxicity can be strategically repurposed for cancer therapy. This review summarizes the mechanism by which NMs selectively activate specific cellular processes to regulate cell fate independently. We also discussed how NMs‐induced biological responses can be leveraged as therapeutic strategies for cancer treatment.
Liting Wang, Hao Fu, Jiangtao Lin, Meng Zhao, Chuanrong Chen, Hongze Liao, Yourong Duan   +6 more
wiley   +1 more source

Primary hepatic leiomyosarcoma concurrent with early-stage lung adenocarcinoma: a rare case report. [PDF]

Front Oncol
Peng W, Xiao X, Li L, Yu Y.
europepmc   +1 more source

A Solution for Exosome‐Based Analysis: Surface‐Enhanced Raman Spectroscopy and Artificial Intelligence

Advanced Intelligent Discovery, EarlyView.
Exosomes are emerging as powerful biomarkers for disease diagnosis and monitoring. This review highlights the integration of surface‐enhanced Raman spectroscopy with artificial intelligence to enhance molecular fingerprinting of exosomes. Machine learning and deep learning techniques improve spectral interpretation, enabling accurate classification of ...
Munevver Akdeniz, Zakarya Al‐Shaebi, Omer Aydin   +2 more
wiley   +1 more source

Pan-cancer analysis reveals ASCC family promotes the cancer progression of lung adenocarcinoma. [PDF]

Sci Rep
Pan Y, Tan J, Wu C, Liu C, Chen Z, Zhu Y, Luo F, Liu Q.   +7 more
europepmc   +1 more source

Association Between Moraxella catarrhalis and Nodular Lymphocyte‐Predominant Hodgkin Lymphoma

American Journal of Hematology, EarlyView.
ABSTRACT Nodular lymphocyte‐predominant Hodgkin Lymphoma (NLPHL) may be an antigen‐driven malignancy. Recent studies demonstrated that in NLPHL patients, lymphoma B‐cell receptor can bind proteins derived from Moraxella catarrhalis (MC) and Rothia mucilaginosa (RM). We examined whether MC and RM can be detected in NLPHL lymph nodes.
Izidore S. Lossos, Xiaoyu Jiang, Krishna Patel, Kamilia N. Moalem, Jordan Laser, Joo Y. Song, Anamarija M. Perry, Jennifer R. Chapman   +7 more
wiley   +1 more source

Animal models of lung cancer: Phenotypic comparison of different animal models of lung cancer and their application in the study of mechanisms

Animal Models and Experimental Medicine, EarlyView.
Grafts used to construct lung cancer animal models come from various sources, primarily cell lines, patient‐derived tumor tissues, and circulating tumor cells. Based on the sources of grafts and research objectives, lung cancer animal models can be categorized into several types: chemical‐induced models, orthotopic transplantation models, heterotopic ...
Zixuan Yang, Xianbin Zhao, Lili Tan, Pingxinyi Que, Tong Zhao, Wei Huang, Dejiao Yao, Songqi Tang   +7 more
wiley   +1 more source